According to the new market research report “Liver Disease Diagnostics – Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”, published by QYResearch, the global Liver Disease Diagnostics market size is projected to reach USD 21.29 billion by 2030, at a CAGR of 6.7% during the forecast period.
- Global Liver Disease Diagnostics MarketSize(US$ Million), 2019-2030
Source: QYResearch, “Liver Disease Diagnostics – Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
- Global Liver Disease Diagnostics Top14Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)
Source: QYResearch, “Liver Disease Diagnostics – Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
According to QYResearch Top Players Research Center, the global key manufacturers of Liver Disease Diagnostics include Roche, Abbott, Thermo Fisher Scientific, Siemens Healthineers, GE Healthcare, Canon Medical Systems, LabCorp, BD, Philips Healthcare, Randox Laboratories, etc. In 2023, the global top five players had a share approximately 25.0% in terms of revenue.
- Liver Disease Diagnostics,Global Market Size, Split by Product Segment
Source: QYResearch, “Liver Disease Diagnostics – Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
In terms of product type, currently Imaging Tests is the largest segment, hold a share of 60.0%.
- Liver Disease Diagnostics,Global Market Size, Split by ApplicationSegment
Source: QYResearch, “Liver Disease Diagnostics – Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
In terms of product application, currently Hospitals and Clinics is the largest segment, hold a share of 71.9%.
- Liver Disease Diagnostics,Global Market Size, Split by Region
Source: QYResearch, “Liver Disease Diagnostics – Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
Market Drivers:
D1: Increasing prevalence of liver diseases. The rising global burden of liver diseases, including viral hepatitis, NAFLD, and liver cancer, is a significant driver for the market. Factors such as alcohol consumption, obesity, and viral infections contribute to the increasing incidence of these diseases.
D2: Advancements in diagnostic technologies. Technological advancements in liver disease diagnostics, such as the development of molecular diagnostic techniques, biomarker assays, and imaging modalities, have improved the accuracy, efficiency, and speed of diagnosis. These advancements have positively impacted the market growth.
D3: Increasing awareness and screening programs. Growing awareness about liver diseases, along with the implementation of screening programs by governments and healthcare organizations, has resulted in early detection and timely treatment. This has led to an increased demand for liver disease diagnostics.
Restraint:
R1: In certain regions, especially low-income countries, there is a lack of awareness about liver diseases, resulting in limited access to diagnostic facilities and infrastructure. This hampers the market growth, as many individuals remain undiagnosed or receive delayed diagnosis.
R2: The liver disease diagnostics market is subject to stringent regulatory requirements, including the need for validation studies, quality control, and compliance with regulatory guidelines. These regulatory hurdles can slow down the approval process for new diagnostic tests and technologies.
R3: The cost associated with liver disease diagnostic tests, especially advanced molecular and genetic testing, can be a significant barrier, particularly in developing countries with limited healthcare budgets. The high cost of these tests can hinder their widespread adoption.
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)
EN: https://www.qyresearch.com
JP: https://www.qyresearch.co.jp